What Can Investors Learn From Cannabis Legalization in Washington and Colorado?

Data from U.S. states may inform provincial decision making as Aphria Inc. (TSX:APH) and Canopy Growth Corp. (TSX:WEED) tread lightly around U.S. federal laws.

| More on:

Provincial governments in Canada are wrestling with the challenges of cannabis legalization as the Federal Government targets a summer 2018 legalization date. Some of the issues bandied about by politicians are child safety in the wake of legalization, how consumption will change impaired driving laws, and, a crucial point for politicians and bureaucrats, how tax revenue will be extracted.

A Nanos Research poll of 1,000 Canadians revealed divisions on these points. In setting the rules, 57% of respondents said the Federal Government should lay the groundwork, 32% want the responsibility to go to the provinces, and 11% are unsure.

In late 2016, advocacy leader the Drug Policy Alliance (DPA) released a report on developments in the states of Washington and Colorado, where commercial cannabis markets have been open and operating for three years.

State surveys showed that cannabis use among teenagers was unchanged since legalization. Legalization opponents often point to the potential dangers that use can have at early ages. These groups could point out the increase in rates of cannabis poisoning, 47 cases in 2015 (up from 25 in 2013) among small children in Colorado. Note that cannabis accounts for only 2.3 of every 1,000 poison control case for children 10 and younger in the state. Rates of poisoning are also dwarfed by tobacco cases in children.

As far as impacts on driving are concerned, the DPA writes: “Post-legalization traffic fatality rate has remained statistically consistent with pre-legalization levels …  and is lower than the national rate.” Data released from the Cato Institute in 2015 and 2016 was consistent with the conclusions reached in these findings.

The DPA also found that tax revenues had exceeded projections in Washington and Colorado. Still, the increase represented less than 1% of state expenditures for both.

Shares of Aphria Inc. (TSX:APH) fell 11% in the week of July 31 to August 4. This was after the stock shot up in the wake of Q4 results that demonstrated the company had slashed production costs. On August 4, the stock fell 3.2% to close at $5.75. On July 28, CEO Vic Neufeld said an announcement was coming soon that the company hopes will reconcile cannabis companies with investments in the U.S., where it is still illegal on a federal level.

Canopy Growth Corp. (TSX:WEED) stock also experienced a 2.95% decline over the course of the same week. On August 4, Canopy Growth reiterated that it will only conduct business in jurisdictions where it is legal on a federal level. Bruce Linton, chairman and CEO of Canopy Growth, chimed in: “Canopy Growth investors can feel confident that they are not being exposed to undue risks.”

Cannabis stocks like Aphria and Canopy Growth are demonstrating some of the volatility investors have been used to in 2017. Long term, the outlook is still extremely bright, but in the short and medium term, volatility will likely reign before the provinces hash out substantive plans. If developments in Washington and Colorado are any indication, legalization may not provide the social and political earthquake that politicians are projecting.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Ambrose O'Callaghan has no position in any stocks mentioned.

More on Investing

woman retiree on computer
Dividend Stocks

Should You Buy Telus Stock at $20?

Down 40% from all-time highs, Telus is a beaten-down TSX dividend stock that trades at a discount to consensus price…

Read more »

top TSX stocks to buy
Dividend Stocks

Here’s Exactly How $15,000 in a TFSA Could Grow Into $200,000

Canadians with sizeable TFSA balances today have utilized the full potential of the investment vehicle.

Read more »

clock time
Investing

Building Generational Wealth: Why Now Is Still the Time to Invest in Canadian Stocks

Here's why Canadian stocks should still be the core of your investment portfolio.

Read more »

TFSA (Tax-Free Savings Account) on wooden blocks and Canadian one hundred dollar bills.
Dividend Stocks

The 1 Canadian Stock I’d Buy and Hold Forever in a TFSA

Don't get complicated. Consider this Canadian stock as a long-time buy.

Read more »

Man data analyze
Dividend Stocks

A Top-Performing U.S. Stock That Canadian Investors Really Should Own

This top US tech stock is something you cannot miss out on, and there’s another from Canada that you need…

Read more »

how to save money
Dividend Stocks

3 Premium TSX Dividend Stocks Worth Loading Up On

These three premium TSX dividend stocks remain among the best bets for long-term investors seeking stable total returns.

Read more »

Hand Protecting Senior Couple
Dividend Stocks

3 Canadian Dividend Stocks Perfect for Retirees

These three Canadian stocks are ideal for retirees.

Read more »

Retirees sip their morning coffee outside.
Retirement

Here’s Why You Might Want to Claim CPP at 60 

Are you considering claiming CPP at 60 but are worried if the decision is right? Consider these things before deciding…

Read more »